New White Paper on Digital Opinion Leaders

It seems nothing (and no one) in our modern world has escaped the changes brought on by a migration to the digital space. In the pharmaceutical and life sciences category, the key opinion leader (KOL) is no exception. Digital opinion leaders (DOLs) have taken an ever-growing role in shaping treatment and disease management discussions. COVID-19 and the global response to the pandemic has hastened the rise of DOLs by restricting in-person activities such as congresses, meetings, and even operating in a clinic.

To read more, kindly provide your name & email to access the full white paper.

More Posts

New White Paper on Patient Engagement

Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the

New White Paper on Building Speakers Bureaus

The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs


Send Us A Message